13-36295796-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001144981.3(CCDC169):c.145C>T(p.Leu49Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000117 in 1,533,178 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144981.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC169 | NM_001144981.3 | c.145C>T | p.Leu49Phe | missense_variant | 2/8 | ENST00000239859.8 | NP_001138453.1 | |
CCDC169-SOHLH2 | NM_001198910.2 | c.-97+1841C>T | intron_variant | NP_001185839.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC169 | ENST00000239859.8 | c.145C>T | p.Leu49Phe | missense_variant | 2/8 | 5 | NM_001144981.3 | ENSP00000239859 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000128 AC: 2AN: 155684Hom.: 0 AF XY: 0.0000122 AC XY: 1AN XY: 82288
GnomAD4 exome AF: 0.00000434 AC: 6AN: 1381028Hom.: 1 Cov.: 25 AF XY: 0.00000293 AC XY: 2AN XY: 682204
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 05, 2024 | The c.145C>T (p.L49F) alteration is located in exon 2 (coding exon 2) of the CCDC169 gene. This alteration results from a C to T substitution at nucleotide position 145, causing the leucine (L) at amino acid position 49 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at